Myocarditis and myasthenia gravis by combined nivolumab and ipilimumab immunotherapy for renal cell carcinoma: A case report of successful management

Ipilimumab plus nivolumab (Ipi/Nivo) has revolutionized advanced renal cell carcinoma (RCC) treatment. However, it encompassed fatal immune-related adverse events (irAEs). Myocarditis with concomitant myasthenia gravis (MG) has a mortality rate of 50%, and a high dose of methylprednisolone (mPSL) sh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Urol Case Rep
Egile Nagusiak: Yanase, Takahiro, Moritoki, Yoshinobu, Kondo, Hajime, Ueyama, Daigo, Akita, Hidetoshi, Yasui, Takahiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7726655/
https://ncbi.nlm.nih.gov/pubmed/33318935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2020.101508
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak